Logo image of BTSGU

BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 (BTSGU) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:BTSGU - US10950A2050

119.38 USD
-2.99 (-2.44%)
Last: 12/2/2025, 8:00:02 PM
Fundamental Rating

4

Taking everything into account, BTSGU scores 4 out of 10 in our fundamental rating. BTSGU was compared to 101 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of BTSGU get a neutral evaluation. Nothing too spectacular is happening here. BTSGU shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

BTSGU had positive earnings in the past year.
BTSGU had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: BTSGU reported negative net income in multiple years.
BTSGU had a positive operating cash flow in 4 of the past 5 years.
BTSGU Yearly Net Income VS EBIT VS OCF VS FCFBTSGU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

BTSGU has a Return On Assets of 2.14%. This is comparable to the rest of the industry: BTSGU outperforms 58.42% of its industry peers.
BTSGU has a better Return On Equity (7.13%) than 66.34% of its industry peers.
The Return On Invested Capital of BTSGU (4.68%) is comparable to the rest of the industry.
BTSGU had an Average Return On Invested Capital over the past 3 years of 3.45%. This is significantly below the industry average of 9.22%.
The last Return On Invested Capital (4.68%) for BTSGU is above the 3 year average (3.45%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.14%
ROE 7.13%
ROIC 4.68%
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
BTSGU Yearly ROA, ROE, ROICBTSGU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

Looking at the Profit Margin, with a value of 1.04%, BTSGU is in line with its industry, outperforming 58.42% of the companies in the same industry.
The Operating Margin of BTSGU (2.15%) is comparable to the rest of the industry.
BTSGU's Operating Margin has improved in the last couple of years.
BTSGU has a Gross Margin of 12.30%. This is in the lower half of the industry: BTSGU underperforms 71.29% of its industry peers.
BTSGU's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.15%
PM (TTM) 1.04%
GM 12.3%
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
BTSGU Yearly Profit, Operating, Gross MarginsBTSGU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BTSGU is destroying value.
BTSGU has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BTSGU has been increased compared to 5 years ago.
The debt/assets ratio for BTSGU has been reduced compared to a year ago.
BTSGU Yearly Shares OutstandingBTSGU Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
BTSGU Yearly Total Debt VS Total AssetsBTSGU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

BTSGU has an Altman-Z score of 5.47. This indicates that BTSGU is financially healthy and has little risk of bankruptcy at the moment.
BTSGU has a Altman-Z score of 5.47. This is amongst the best in the industry. BTSGU outperforms 88.12% of its industry peers.
BTSGU has a debt to FCF ratio of 9.17. This is a negative value and a sign of low solvency as BTSGU would need 9.17 years to pay back of all of its debts.
With a Debt to FCF ratio value of 9.17, BTSGU perfoms like the industry average, outperforming 47.52% of the companies in the same industry.
A Debt/Equity ratio of 1.36 is on the high side and indicates that BTSGU has dependencies on debt financing.
BTSGU has a worse Debt to Equity ratio (1.36) than 67.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.36
Debt/FCF 9.17
Altman-Z 5.47
ROIC/WACC0.53
WACC8.78%
BTSGU Yearly LT Debt VS Equity VS FCFBTSGU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

BTSGU has a Current Ratio of 1.79. This is a normal value and indicates that BTSGU is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.79, BTSGU is in the better half of the industry, outperforming 68.32% of the companies in the same industry.
A Quick Ratio of 1.38 indicates that BTSGU should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.38, BTSGU is in line with its industry, outperforming 56.44% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.79
Quick Ratio 1.38
BTSGU Yearly Current Assets VS Current LiabilitesBTSGU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 117.02% over the past year.
BTSGU shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.23%.
The Revenue has been growing by 20.01% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)117.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%254.55%
Revenue 1Y (TTM)17.23%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%14.7%

3.2 Future

The Earnings Per Share is expected to grow by 43.45% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 15.41% on average over the next years. This is quite good.
EPS Next Y85.44%
EPS Next 2Y54.69%
EPS Next 3Y43.24%
EPS Next 5Y43.45%
Revenue Next Year12.92%
Revenue Next 2Y13.3%
Revenue Next 3Y13.01%
Revenue Next 5Y15.41%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
BTSGU Yearly Revenue VS EstimatesBTSGU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B 20B
BTSGU Yearly EPS VS EstimatesBTSGU Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 0 1 2 3

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 117.04, BTSGU can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as BTSGU.
When comparing the Price/Earnings ratio of BTSGU to the average of the S&P500 Index (26.15), we can say BTSGU is valued expensively.
The Price/Forward Earnings ratio is 90.70, which means the current valuation is very expensive for BTSGU.
Based on the Price/Forward Earnings ratio, BTSGU is valued a bit more expensive than 61.39% of the companies in the same industry.
BTSGU's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 36.22.
Industry RankSector Rank
PE 117.04
Fwd PE 90.7
BTSGU Price Earnings VS Forward Price EarningsBTSGU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BTSGU indicates a slightly more expensive valuation: BTSGU is more expensive than 60.40% of the companies listed in the same industry.
BTSGU's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 77.98
EV/EBITDA 53.65
BTSGU Per share dataBTSGU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

BTSGU's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
BTSGU's earnings are expected to grow with 43.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.37
PEG (5Y)N/A
EPS Next 2Y54.69%
EPS Next 3Y43.24%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.80%, BTSGU has a reasonable but not impressive dividend return.
BTSGU's Dividend Yield is rather good when compared to the industry average which is at 2.47. BTSGU pays more dividend than 96.04% of the companies in the same industry.
BTSGU's Dividend Yield is a higher than the S&P500 average which is at 2.32.
Industry RankSector Rank
Dividend Yield 2.8%

5.2 History

BTSGU is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BTSGU Yearly Dividends per shareBTSGU Yearly Dividends per shareYearly Dividends per share 2024 2025 1 2 3

5.3 Sustainability

DPN/A
EPS Next 2Y54.69%
EPS Next 3Y43.24%
BTSGU Yearly Income VS Free CF VS DividendBTSGU Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27

NASDAQ:BTSGU (12/2/2025, 8:00:02 PM)

119.38

-2.99 (-2.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-20 2025-10-20/amc
Earnings (Next)01-19 2026-01-19/bmo
Inst Owners70.16%
Inst Owner ChangeN/A
Ins Owners2.57%
Ins Owner ChangeN/A
Market Cap21.53B
Revenue(TTM)12.41B
Net Income(TTM)129.59M
Analysts84.21
Price Target135.93 (13.86%)
Short Float %0.05%
Short Ratio1.81
Dividend
Industry RankSector Rank
Dividend Yield 2.8%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date10-15 2025-10-15 (0.8438)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.94%
Min EPS beat(2)26.26%
Max EPS beat(2)41.61%
EPS beat(4)3
Avg EPS beat(4)40.55%
Min EPS beat(4)-2.7%
Max EPS beat(4)97.01%
EPS beat(8)5
Avg EPS beat(8)26.15%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.23%
Min Revenue beat(2)3.22%
Max Revenue beat(2)3.24%
Revenue beat(4)3
Avg Revenue beat(4)2.17%
Min Revenue beat(4)-0.62%
Max Revenue beat(4)3.24%
Revenue beat(8)6
Avg Revenue beat(8)2.96%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)21.49%
PT rev (3m)33.93%
EPS NQ rev (1m)9.57%
EPS NQ rev (3m)12.68%
EPS NY rev (1m)-0.55%
EPS NY rev (3m)16.29%
Revenue NQ rev (1m)2.28%
Revenue NQ rev (3m)2.01%
Revenue NY rev (1m)1.31%
Revenue NY rev (3m)1.4%
Valuation
Industry RankSector Rank
PE 117.04
Fwd PE 90.7
P/S 1.73
P/FCF 77.98
P/OCF 61.65
P/B 11.84
P/tB N/A
EV/EBITDA 53.65
EPS(TTM)1.02
EY0.85%
EPS(NY)1.32
Fwd EY1.1%
FCF(TTM)1.53
FCFY1.28%
OCF(TTM)1.94
OCFY1.62%
SpS68.83
BVpS10.08
TBVpS-5.95
PEG (NY)1.37
PEG (5Y)N/A
Graham Number15.21
Profitability
Industry RankSector Rank
ROA 2.14%
ROE 7.13%
ROCE 5.92%
ROIC 4.68%
ROICexc 4.83%
ROICexgc 14.34%
OM 2.15%
PM (TTM) 1.04%
GM 12.3%
FCFM 2.22%
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
ROICexc(3y)3.47%
ROICexc(5y)3.63%
ROICexgc(3y)17.05%
ROICexgc(5y)18.21%
ROCE(3y)4.37%
ROCE(5y)4.5%
ROICexgc growth 3Y-9.4%
ROICexgc growth 5Y19.06%
ROICexc growth 3Y-3.14%
ROICexc growth 5Y18.48%
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
F-Score7
Asset Turnover2.05
Health
Industry RankSector Rank
Debt/Equity 1.36
Debt/FCF 9.17
Debt/EBITDA 5.55
Cap/Depr 40.71%
Cap/Sales 0.59%
Interest Coverage 1.44
Cash Conversion 78.31%
Profit Quality 213.06%
Current Ratio 1.79
Quick Ratio 1.38
Altman-Z 5.47
F-Score7
WACC8.78%
ROIC/WACC0.53
Cap/Depr(3y)36.76%
Cap/Depr(5y)33.73%
Cap/Sales(3y)0.82%
Cap/Sales(5y)0.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)117.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%254.55%
EPS Next Y85.44%
EPS Next 2Y54.69%
EPS Next 3Y43.24%
EPS Next 5Y43.45%
Revenue 1Y (TTM)17.23%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%14.7%
Revenue Next Year12.92%
Revenue Next 2Y13.3%
Revenue Next 3Y13.01%
Revenue Next 5Y15.41%
EBIT growth 1Y36.15%
EBIT growth 3Y-4.13%
EBIT growth 5Y26.66%
EBIT Next Year60.02%
EBIT Next 3Y26.18%
EBIT Next 5Y28.14%
FCF growth 1Y324.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y820.28%
OCF growth 3Y-55.52%
OCF growth 5Y-26.51%

BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 / BTSGU FAQ

What is the fundamental rating for BTSGU stock?

ChartMill assigns a fundamental rating of 4 / 10 to BTSGU.


What is the valuation status for BTSGU stock?

ChartMill assigns a valuation rating of 2 / 10 to BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 (BTSGU). This can be considered as Overvalued.


What is the profitability of BTSGU stock?

BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 (BTSGU) has a profitability rating of 4 / 10.


What is the valuation of BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 (BTSGU) is 117.04 and the Price/Book (PB) ratio is 11.84.


Can you provide the financial health for BTSGU stock?

The financial health rating of BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 (BTSGU) is 4 / 10.